FDA Breakthrough Therapy Designation granted to lacutamab for relapsed or refractory Sézary syndrome New data, including lacutamab improved health-related quality of life data from TELLOMAK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback